These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 17018759)
41. Integrating aprepitant and palonosetron into clinical practice: a role for the new antiemetics. Viale PH Clin J Oncol Nurs; 2005 Feb; 9(1):77-84. PubMed ID: 15751501 [TBL] [Abstract][Full Text] [Related]
42. Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer. Glare P; Pereira G; Kristjanson LJ; Stockler M; Tattersall M Support Care Cancer; 2004 Jun; 12(6):432-40. PubMed ID: 15108099 [TBL] [Abstract][Full Text] [Related]
43. Olanzapine for nausea and vomiting. Licup N Am J Hosp Palliat Care; 2010 Sep; 27(6):432-4. PubMed ID: 20508243 [TBL] [Abstract][Full Text] [Related]
45. Management of nausea and vomiting caused by anticancer drugs: state of the art. Pisters KM; Kris MG Oncology (Williston Park); 1992 Feb; 6(2 Suppl):99-104. PubMed ID: 1532744 [TBL] [Abstract][Full Text] [Related]
46. [Nausea and vomiting induced by anticancer chemotherapy: mechanisms and prevention]. Bonneterre J; Adenis L Pathol Biol (Paris); 1989 Feb; 37(2):163-4. PubMed ID: 2652072 [No Abstract] [Full Text] [Related]
47. Oh, what a tangled web. Grunberg SM J Clin Oncol; 1989 Jun; 7(6):691-3. PubMed ID: 2715799 [No Abstract] [Full Text] [Related]
48. Clinical practice guidelines on antiemetics in oncology. Aranda Aguilar E; Constenla Figueiras M; Cortes-Funes H; Diaz-Rubio García E; Gascon Vilaplana P; Guillém V; Martin-Algarra S Expert Rev Anticancer Ther; 2005 Dec; 5(6):963-72. PubMed ID: 16336087 [TBL] [Abstract][Full Text] [Related]
49. Synthetic marijuana for nausea and vomiting due to cancer chemotherapy. Med Lett Drugs Ther; 1985 Nov; 27(701):97-8. PubMed ID: 2999571 [No Abstract] [Full Text] [Related]
50. Chemotherapy-induced nausea and vomiting: contemporary approaches to optimal management. Proceedings from a symposium at the 2008 Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting. Grunberg S; Clark-Snow RA; Koeller J Support Care Cancer; 2010 Mar; 18 Suppl 1():S1-10. PubMed ID: 20084406 [TBL] [Abstract][Full Text] [Related]
51. A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting. Jones SE; Durant JR; Greco FA; Robertone A Cancer Treat Rev; 1982 Dec; 9 Suppl B():45-8. PubMed ID: 6299555 [No Abstract] [Full Text] [Related]
52. Evaluation of antiemetic practices for prevention of chemotherapy-induced nausea and vomiting (CINV): results of a European oncology nurse survey. Dielenseger P; Börjeson S; Vidall C; Young A; Jahn P Support Care Cancer; 2019 Nov; 27(11):4099-4106. PubMed ID: 30783815 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of an anti-emetic protocol. Cook J; Gallagher A Paediatr Nurs; 1996 Sep; 8(7):21-3. PubMed ID: 9070770 [No Abstract] [Full Text] [Related]
55. The current role of anti-emetic drugs in oncology: a recent revolution in patient symptom control. Sagar SM Cancer Treat Rev; 1991 Jun; 18(2):95-135. PubMed ID: 1804527 [No Abstract] [Full Text] [Related]
56. [Models, projects of health participation]. Scurti V; Sichetti D; Valerio M Assist Inferm Ric; 2005; 24(4):204-8. PubMed ID: 16550700 [No Abstract] [Full Text] [Related]
57. [Antiemetics during cytotoxic treatments]. Pouillart P Rev Prat; 1993 Apr; 43(8):1001-6. PubMed ID: 8341964 [No Abstract] [Full Text] [Related]
58. Phase I-trial of clebopride, a new antiemetic, in chemotherapy--induced nausea and vomiting. Lenz HJ; Schuler U; Hicking W; Ehninger G Eur J Clin Pharmacol; 1990; 38(5):525. PubMed ID: 2379541 [No Abstract] [Full Text] [Related]
59. [Gastrointestinal side effects of anticancer agents and their counter measures]. Nakao I Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):928-30. PubMed ID: 2160800 [No Abstract] [Full Text] [Related]